COVID, Novavax
The new COVID-19 vaccine: To get or not to get?
On Aug. 22, the U.S. Food and Drug Administration announced the approval of a new Novavax COVID vaccine, as well as updated versions of the Pfizer-BioNTech and Moderna vaccines. According to NPR, this latest vaccine is already being distributed and administered across the country.
Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday ...
Pfizer Inc. ( PFE, Financial) rose to prominence during the Covid-19 pandemic for its rapid development of a vaccine and ...
Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine ...
The Ministry of Food and Drug Safety approved Novavax's vaccine for emergency use today (30th) in response to the "COVID-19 ...
Pfizer and BioNTech’s updated COVID-19 vaccine targeting the KP.2 strain, a descendant of JN.1, has been recommended by the ...
Babies under six months can't be vaccinated directly against COVID. A new study found that most infants hospitalized for ...
Pfizer-BioNTech's updated vaccine to protect against a recently circulating variant of COVID-19 is authorized, Health Canada said on Tuesday.
Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently ...
The mRNA vaccine, called Comirnaty, targets the KP.2 subvariant of Omicron, replacing the previous version which targeted the ...
Along with the annual flu vaccine, the new COVID-19 vaccine formulation is now widely available in Minnesota. It comes at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback